# Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

> **NCT00006011** · PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 659 (actual)

## Conditions studied

- Endometrial Adenocarcinoma
- Endometrial Adenosquamous Carcinoma
- Endometrial Clear Cell Adenocarcinoma
- Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
- Endometrial Serous Adenocarcinoma
- Stage III Uterine Corpus Cancer

## Interventions

- **DRUG:** Doxorubicin Hydrochloride
- **DRUG:** Cisplatin
- **BIOLOGICAL:** Filgrastim
- **BIOLOGICAL:** Pegfilgrastim
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00006011
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2015-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006011, "Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00006011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*